Published in Blood Weekly, September 16th, 1996
The use of a hemoglobin-based oxygen carrier (HBOC) as volume replacement after normovolemic hemodilution may decrease the complications associated with hemodilution, noted B.J. Leone, M.D., Duke University Medical Center, Durham, North Carolina, and colleagues (Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1996;24(4):abstract 379).
The research was performed with investigators from Somatogen, Inc., Boulder, Colorado, and presented at the VI International Symposium on Blood Substitutes, held August...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.